Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Ann Surg Oncol. 2010 Feb 2;17(4):953–958. doi: 10.1245/s10434-010-0919-1

TABLE 1.

Base-case probability and cost estimates and their ranges for sensitivity analysis

Base-case estimate (min/max) References
Probabilities
Metastasis prevalence 0.30 (0.15/0.45) 2,3
Ultrasound sensitivity 0.63 (0.26/0.92) 5,7
Ultrasound specificity 0.91 (0.44/0.98) 5,7
FNA sensitivity 0.65 (0.06/0.95) 5,7
FNA specificity 0.99 (0.90/1.00) 5,7
SLN surgery sensitivity 0.93 (0.77/0.98) 6,812
SLN surgery specificity 0.99 (0.90/1.00) 6,812
Costs
SLN surgery $10,078 ($6,522/$17,473) Patient data
ALND $11,045 ($7,250/$19,315) Patient data
SLN surgery and ALND $13,321 ($8,402/$23,537) Patient data
FNA with imaging guidance $128 ($64/$512) Medicare reimbursement
Ultrasound of breast $98 ($49/$392) Medicare reimbursement
Echo guidance for biopsy $206 ($103/$824) Medicare reimbursement
Cytopathology evaluation for FNA $142 ($71/$568) Medicare reimbursement

ALND axillary lymph node dissection, FNA fine-needle aspiration, SLN sentinel lymph node